Bernhard K Keppler

29PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Main group metal chemistryMolecular targetsTransition metal chemistryBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|May 22, 2026
Combinational studies of BOLD-100/KP1339 with established chemotherapeutics in gastrointestinal multicellular tumor spheroids.

|Sep 29, 2025
Exploring the Anticancer Properties of 4-Phenylthiazole-Based Ru(II) and Os(II) Metallacycles Featuring 1-Methylimidazole as N-Donor Functionality.

Paul Getreuer, Theresa Mendrina, Steven van Terwingen

|Aug 06, 2025
Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate.

Alexander Rosner, Lukas Skos, Theresa Mendrina

|Mar 12, 2024
Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103.

B Happl, T Balber, P Heffeter

|Mar 01, 2024
Investigating the anticancer potential of 4-phenylthiazole derived Ru(II) and Os(II) metalacycles.

Paul Getreuer, Laura Marretta, Emine Toyoglu

|Sep 13, 2023
Insertion of (Bioactive) Equatorial Ligands into Platinum(IV) Complexes.

Alexander Kastner, Hemma Schueffl, Patrick A Yassemipour

Pageof 5

Frequent Collaborators

14 joint publications

Michael A Jakupec

10 joint publications

Petra Heffeter

10 joint publications

Walter Berger

9 joint publications

Wolfgang Kandioller